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Abstract  
Sickle cell disease (SCD) is known to be one of the diseases wrecking most parts of the globe without any discrimination of 
ethnic or racial standards. It is characterized by a variety of symptoms including, shortness of breath, heart palpitations, 
abdominal pains, aches and pains in the muscle. The crisis stage is characterized by severe pain in the head and whole body. 
In the stage of crises if the percentage of sickled erythrocytes can be some how lowered we can expect a great relief to the 
patient. This could also serve a major step to-words management of the SCD. Phytochemicals in the plant extracts have the 
therapeutic activity and is used in traditional practice by the traditional healers. Many plant extracts have been used to bring 
about reversal of the sickled erythrocytes in vitro.  The present communication reviews the available literature reporting anti-
sickling properties of a number of plants extracts on human blood samples. 
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INTRODUCTION 
 
     Since the beginning of time plants have been recognized for 
their several lifesaving and therapeutic properties [1]. Lifestyle and 
eating habitsalterations among thepeople makes it vital to refer to 
herbal medicine as an alternative or complimentary therapeutic 
measure. Nearly 70% world population (mainly in the developing 
countries) rely entirely on such traditional medical therapies as their 
primary form of health care [2, 3]. Various herbs are also a part of 
socio-cultural and socio-economic heritage. Even in the present 
times rural populations turn to herbal medicine as the most preferred 
therapeutic source. 
     Phytochemicals in the plant extracts have the therapeutic 
activity and is used in traditional practice by the traditional healers. A 
substance found in medicinal plants, containing the healing property 
of plants [4] is known as the active principle. It differs  from  plant  
to  plant  and  examples  of  active  principles  include:  
anthraquinones,  flavonoids, glycosides, saponins, tannins etc. 
Plants also contain other compounds such as morphine, atropine, 
codeine, steroids, lactones and volatile oils, which possess medical 
values for the treatment of different diseases. In recent years, these 
active principles have been extracted and used in different forms 
such as infusions, syrups, concoctions, decoctions, infused oils, 
essential oils, ointments and creams [5, 6].Since most plants have 
medicinal properties, it is of utmost importance that their efficacy and 
toxicity risks are evaluated [1]. 
     Sickle cell disease (SCD) is known to be one of the diseases 
wrecking most parts of the globewithout any discrimination of ethnic 
or racial standards.The initial record of the disease id from a medical 
studentwho complained of shortness of breath, heart palpitations, 
abdominal pains, aches and pains in the muscle. Theshape of the 
red blood cells was then used to describe his observations [7]. 
According to reports, Africa is believed to be the origin of sickle cell 
disease, and those afflicted with the disease are huge [8, 9]. The 
crisis part of the sickle cell patients is characterized by severe pain 
and breathlessness making it one of the most dreaded of all genetic 
diseases [8, 9, 10 & 11]. 
     Sickle cell crises have been investigated in top priority by 
researchers all around the world in order to explore effective therapy 
towards solving the sickle cell disease problem.  Consequent upon 
this, anti-sickling effects of different substances have been 
investigated. The potential of dried fish and shrimp extractsto inhibit 
polymerization of sickle cell haemoglobin (HbS), improve the iron 
status and lower the activity of lactate dehydrogenase (LDH) in the 
blood plasma. LDH is a sensitive indicator of haemolysis and its level 
in sickle cell blood determines the severity of crises [9]. Various 
chemicals such as Hydroxyurea and erythropoietin concoctions have 
been found to reduce LDH enzyme activity and bilirubin level in 
serum, with an increase in the level of foetal hemoglobin (HbF) [10, 
11]. There have also been reports on effective management of SCD 
patients during pregnancy [12, 13]. 
     In developing countries, medicinal plants have been used in 
the treatment of sickle cellcrises associated morbidiesamong the 
less privileged classes of the society. Traditional healers and local 
folks are known to possess knowledge of the traditional and healing 
properties of various herbs common to their locality.  There is also 
an immense need to gather such knowledge from different 
geographical parts in order to compile all information in the form of a 
database which could be utilized by researchers all over the world. 
 
Sickle Cell Disease 
 
     Sickle cell disease (SCD) is the result of the insertion of a 
glutamic acid with valine at the sixth position of the beta-globin chain 
of haemoglobin S (HbS) [14] with the possibility for various amino-
acids to be get transposed simultaneously [15]. Sickle cell disease 
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include those that produce protuberantmedicalexpressions as seen 
during sickle cell anaemia, sickle cell disease, sickle cell trait and an 
array of other related haemoglobinopathies[14, 15]. Pathophysiology 
of sickle cell anaemia, sickle cell disease, sickle cell trait and an 
array of other related haemoglobinopathies are now known to the 
scientific community. This in turn causes the deformation of the 
normal disc biconcave RBC [16]. Due to polymerization of the sickled 
cells, the red cell membrane loses its functional abilities which 
results in loss of potassium and water and a corresponding gain of 
sodium ion. Increased intracellular free calcium occurs during 
sickling [17], resulting in a loss of potassium with accompanying 
movements of chloride and water. Small blood vessels are blocked 
by the clumping of sickled erythrocytes, averting blood supply to 
various organs. The process of de-oxygenation in tissue capillaries 
causes damage to its endothelium, leading to exudation of plasma 
into the surrounding soft tissue. This is characteristic of the soft 
tissue swelling seen in most sickle cell disease patients [18]. 
     The outermembrane of the erythrocytes possesses a compact 
identity which is preserved by the hydration and case of outer 
membrane de-hydration;it loses its identity and acquires the shape of 
a sickle. Nitric oxideis also believed to play a part in sickle cell 
disease. It was reported that it may be beneficial to SCD patients if 
endogenous nitrous oxideproduction is boosted, in turn, boosting the 
nitrous oxide response or loweringit demolition [19]. This is to 
prevent haemoglobin released as a result of haemolysis using the 
nitrous oxide and activating a flow of events that finally hinder blood 
supply. 
 
Clinical Manifestations 
 
     Sickle cell disease has a variety of phenotypes which makes it 
quite confusing to make an diagnosis. Phenotypic expression is 
strikingly different among different patients [20]. Symptoms of sickle 
cell disease are assorted and wide-ranging and can be recognized 
into the following categories- a) Anaemia b) Pain consequences, 
andc) Organ failure. Choking of blood and injured organs results 
inthe experience of painful occurrences or “crises”. Sickle cell crises 
may be caused by blood vessel occlusion, triggered by membrane 
deformation [21]. SCD patients suffer from a variety of ailments 
which includes acute chest syndrome (ACS) which is one of the 
reasons for hospital admissions [22], stroke [23], and acute splenic 
sequestration [24-26]. Other clinical manifestations of this condition 
are hyposthenuria, priapism, vascular necrosis, proliferative 
retinopathy, aplastic crises, cholelithiasis, delayed growth and sexual 
maturation, chronic pulmonary disease and chronic nephropathy 
[27].However all these clinical features of the sickle cell disease do 
not appear until after the first sixth months of life, at which time most 
of the HbF has been replaced by HbS. 
 
Plant Extracts used as Therapeutic Measures  
 
     Plant extracts are found to possess properties which prevent 
the erythrocytes from deforming and losing its integrity. In the 
treatment of SCD, it is required that one focuses on the ways of 
inhibiting sickle cell haemoglobin polymerisation, prevention or repair 
of red cell dehydration and interrupting the interaction of sickle cells 
with the endothelium[17, 28-31]. Lower drug response in SCD 
patients is also seen as a major factor which hinders in the discovery 
of an effective therapy [14]. Hydroxyurea is a known inhibitor of 
sickle cell polymerization and various drugs containing it has an 
ability to increase foetal haemoglobin concentration [32, 33]. 
     Recent therapy focuses on the erythrocytic rehydration [33, 
34]. Management of sickle cell disease (SCD) hence, involves 
substances which has an ability to rehydrate the erythrocytes and 
furthermore, preventing it from losing its shape. The anti-sickling 
properties of certain amino acids such as phenylalanine, alanine, 
lysine, arginine etc., have also been reported [35, 36].Many plant 
extracts were reported to lower the painful episodes and related 
complications of SCD[37-39].In another report, the importance of 
thiocyanate, hydroxyurea, and telluriteaspotentantisickling agents 
possessing immene potential to inhibit erythrocytic 
deformations.Blood transfusion is also used in the management of 
sickle cell disease and can help the process to a great extent 
[40&41]. One of the drawbacks of blood transfusion was it lowered 
the macrophage count in patients[42-45]. Phytochemicals found in 
extracts ofPiper guineensis, Pterocarpaosun, Eugenia caryophyllala 
andSorghum bicolorcan serve as potential antisickling agents 
[46].Pterocarpussantolinoides and Aloe veraextracts werefound to be 
useful in crisis managementand extracts of Fagarazanthoxylo   
ides and Terminalia catappaextractswere reported to possess 
potential reversal properties [47-49], Solariadulcis[50-51] was also 
used in SCD management. They therefore, used Trypanosome 
brucei to investigate the effect of the plant on haematological and 
biochemical indices due to lack of animal models for assessing the 
effectiveness of the plant extract in sickle cell disease 
monitoring.The following plants were also found to possess potential 
antisickling properties - Alchorneacordifolia, Afromomumalboviolace 
um, Annonasenegalensis, Cymbopogondensiflorus, Bridelia ferru 
ginea, Ceibapentandra, Morindalucida, Hymenocardiaacida, Coleus 
kilimandcharis, Dacryodesedulis, Caloncobawelwithsii, Vignaungui 
culata and Adansoniadigitata L (Bambacacae) [52].  The root 
extracts of Zanthoxylummacrophyllawas also reported to possess 
antisickling properties [53].  
     The potential of Cajanus cajanin the management of sickle 
cell anaemia was also reported [54, 55]. Likewise, garlicwas also 
suggested possessing the same properties [56, 57]. 
     Potential of the fruits of Carica papayafor the sickle cell 
reversal was shown by [58, 59]. Furthermore, extracts from 
Piperguineenses seeds, Pterocapusosumstem, Eugenia 
caryophyllum fruit, and Sorghum bicolor leaves were found to 
possess properties for reversal of sickling of erythrocytes [14, 16].  
 
Phytochemicals responsible for the Anti-sickling properties 
 
     Following reports on the antisickling potentials of plantextracts, 
efforts to identify the causative agent behind it was initiated. There 
ae an array of reports on the varios phytochemical constituents of 
different plant extracts.  The plantsCssuspopulnea L.,  
Khayasenegalensis; Scopariadulcis;  was reported possessing 
anthraquinones, steroidal glycosides and cardiac glycosides along 
withalkaloids and tannins[58-65] 
     Among the role of various phytochemicals in the management 
of SCD the potential of various chemicals have been validated. 
Among the important ones are the divanilloylquinic acids and 2-
dihyroxymethyl benzoic acid isolated and identified from Fagara [66, 
67].The potential of garlic fermented extracts in the treatment and 
management of SCD was also demonstrated [68]. Phytohemicals 
such as thiocyanatewere also studied and reported it to possess 
potential antisickling properties [68-71].  
     Various plants were also found to possess an array of 
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phytochemicals responsible for the reversal of sickled erythrocytes. 
Some of them are M. charantia;Cymbropogoncitratus; 
Camelliasinensis; Scopariadulcis; and Picrorhizakurroa[72-78]. 
 
CURRENT STATUS OF RESEARCH IN THE FIELD 
 
     Works on the reversal of sickling activity has been done by –
[1, 3-9, 10, 12, 13, 16-26, 28, 30-36, 38-44, 46-52, 56-63, 66-88 and 
90-97]Apart from these works, there are no available reports on the 
antisickling properties of plant extracts in our country. Furthermore, 
there are absolutely no reports from Chhattisgarh or Central India. 
Hence, we see that the prospects of further research in this area in 
our country need to be assessed and promoted for the management 
of sickle cell anaemia. 
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